Aetna Given Buy Rating at UBS AG (AET)

Share on StockTwits

UBS AG reiterated their buy rating on shares of Aetna (NYSE:AET) in a research note released on Wednesday morning, American Banking News reports. They currently have a $86.00 target price on the stock, up from their previous target price of $82.00.

Shares of Aetna (NYSE:AET) traded down 0.67% on Wednesday, hitting $72.86. The stock had a trading volume of 987,726 shares. Aetna has a 1-year low of $49.68 and a 1-year high of $74.50. The stock’s 50-day moving average is $69.90 and its 200-day moving average is $66.82. The company has a market cap of $26.426 billion and a price-to-earnings ratio of 13.76.

Aetna (NYSE:AET) last announced its earnings results on Thursday, February 6th. The company reported $1.34 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.36 by $0.02. The company had revenue of $13.13 billion for the quarter, compared to the consensus estimate of $13.14 billion. During the same quarter in the prior year, the company posted $0.94 earnings per share. The company’s quarterly revenue was up 46.7% on a year-over-year basis. On average, analysts predict that Aetna will post $6.38 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, April 25th. Shareholders of record on Thursday, April 10th will be given a dividend of $0.225 per share. This represents a $0.90 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Tuesday, April 8th.

A number of other analysts have also recently weighed in on AET. Analysts at Jefferies Group raised their price target on shares of Aetna to $87.00 in a research note on Friday, March 7th. They now have a buy rating on the stock. Separately, analysts at EVA Dimensions upgraded shares of Aetna from an underweight rating to a hold rating in a research note on Tuesday, March 4th. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Aetna to $75.00 in a research note on Monday, February 10th. Four research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $75.25.

Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.

To view UBS AG’s full report, visit UBS AG’s official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Teva Pharmaceutical Industries Ltd  Now Covered by Analysts at Sterne Agee
Teva Pharmaceutical Industries Ltd Now Covered by Analysts at Sterne Agee
Europa Oil & Gas  Plc Given “Speculative Buy” Rating at Beaufort Securities
Europa Oil & Gas Plc Given “Speculative Buy” Rating at Beaufort Securities
Mitek Systems Upgraded by Zacks to Outperform
Mitek Systems Upgraded by Zacks to Outperform
Reckitt Benckiser Group Plc Stock Rating Reaffirmed by Societe Generale
Reckitt Benckiser Group Plc Stock Rating Reaffirmed by Societe Generale
Linear Technology PT Raised to $42.00
Linear Technology PT Raised to $42.00
EPL Oil & Gas Downgraded by Clarkston Capital to Market Perform
EPL Oil & Gas Downgraded by Clarkston Capital to Market Perform


Leave a Reply

 
© 2006-2014 Mideast Time. Subscribe